The adidas Yeezy Boost 700 V2 Hospital Blue is set to drop this Saturday, September 28th, and early indications suggest this 700 may well outperform previous versions of the silhouette. The Yeezy 700 V2 caught fire upon its initial release of the Static colorway and was immediately one of the most sought-after new Yeezy silhouettes. Since then, the 700 V2 has trailed with a series of bricks, with the Tephra and Geode models trading below retail, and the Vanta and Inertia model barely scraping by with an average price premium of 10%. Could the Hospital Blue be the brick that completes the house? Or could it act as a hero that saves a struggling model? Here is why the Yeezy Boost 700 V2 Hospital Blue has the potential to stick the landing and earn a spot next to the beloved Statics.
Yeezy is no stranger to reiterating existing designs. The first model to receive the sequel treatment was the Yeezy Boost 350 in 2016. Now standing at 29 models deep, some models have shown great success earning sky-high resale prices and premiums, and others have not. This is the case with the 700 V2. As we all know, the Yeezy count continues to climb and just when we think there couldn’t be any more colorways, they appear.
But the V2 version of the 700 has demonstrated reasons for optimism. The Yeezy Boost 700 V2 made its debut in late 2018 in the Static colorway. This release has retained the highest resale value and premiums for its model for going on a year. The average trade value has been recorded at $462 with a premium of 54% and a market high of a whopping $3,500. Yes, you read that correctly. A Static V2 sold for as much as most Nike Air Yeezys sell for. Granted, this was a pre-release sale and prices eventually settled down considerably. Still, this suggests the latest Inertias could do well. The Hospital Blue 700 V2 shares a similar grey tonal mesh upper and would complement outfits just as easily as the Statics. This small similarity could be meaningful when it comes time for resale.
Unfortunately for the 700 V2 silhouettes, the follow-up releases have been burdened with the plague of being a brown sneaker. It’s not easy to sell a brown sneaker. In fact, we can’t think of one brown Yeezy that has ever sat atop the winner’s podium in its class. The Chocolate 750s? Worst selling 750 colorway. The Mauve 700s? Third worst-selling 700 colorway. Brown-toned Yeezys never win, and unfortunately half of the available models of 700 V2s are in Brown tones. Between the Geode and Tephra models, they have generally sold below their retail price, with negative premiums of around -5% on average. That’s a big difference from the Static V2. Just by virtue of the absence of brown in the colorway, the Hospital Blue 700 V2s will likely perform better on the resale market.
Currently, the pre-release price average for the Yeezy Boost 700 V2 Hospital Blue stands at $358, for a premium of just over 19%. How will prices for the adidas Yeezy Boost 700 V2 Hospital Blue respond after their official release, when supply fully hits the market? We believe resale prices will remain steady, showing no large dips. There haven’t been many pre-release trades of this shoe so far, which is somewhat unusual: it’s possible that Yeezy is stepping up their timing for releases, or perhaps buyers are simply waiting to see if they can score at retail.
Based on the evidence so far, it’s likely premiums on the Yeezy Boost 700 V2 Hospital Blue will remain in the positive- not as high as the Statics, but better than the Geode, Tephra, and Inertia models. This Saturday is the opportunity to purchase a shoe that has a good chance to acquire value over time. The run of 700 V2s has just begun. This release is the fifth installation of the model. Surprisingly, the first five models of the 350 V2 from 2016 have retained the highest average resale price for non-reflective 350 V2s, suggesting that early models of any Yeezy silhouette tend to perform best in the long run. Let us hope that this newfound Yeezy Effect will be in full swing for these 700s.